What were the executives at Target Corp., one of America’s most forward-thinking retailers, thinking when, in the midst of a nationwide heroin and opioid surge, they decided to market syringe-styled ink pens during the Halloween season? The product, which trivializes intravenous drug abuse, has angered some prevention activists.
The novelty syringe pens undermine education efforts about IV drug abuse and minimize its dangers. They are no better than the old candy cigarettes, or gum that came in packages that looked like chewing tobacco.
Opioid addiction typically starts with swallowing excessive amounts of prescription painkillers. It progresses to snorting or smoking heroin — a cheaper and more potent drug — and finally to injecting heroin with a needle to get a more potent high.
Styled like a clear hypodermic needle, a six-pack of syringe pens sells for $3. The pen tips resemble needles fastened to syringe-like ink-holders.
Target should pull the products from any of its 1,800 stores that carry them. The company has a solid reputation and should not tarnish that image by trivializing one of the nation’s biggest public health problems.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.